Deepverge PLC New Labskin service - update (2915I)
11 Dicembre 2020 - 8:00AM
UK Regulatory
TIDMDVRG
RNS Number : 2915I
Deepverge PLC
11 December 2020
11 December 2020
DeepVerge PLC
("DeepVerge" or "the Company")
New Labskin service 'soft launched' in August already nets
GBP400,000 in completed orders in Q4
Service has attracted new household name clients
DeepVerge (LSE:DVRG.L), the environmental and life science AI
company, is pleased to announce a new R&D service, launched in
August 2020, has already generated GBP400,000 in completed sales in
Q4 with agreements with 10 new clients that had previously not used
Labskin services. These agreements include framework Master
Services Agreements with 2 of the world's largest suppliers of
consumer products related to skincare.
The new service, designed to quickly validate the impact of
ingredients such as probiotics and prebiotics on the skin
microbiome, clones the human skin microbiome using six microbial
strains and delivers real world environment results that mirror the
impact of treatments and therapeutics on real human skin.
The new R&D service adds to the existing client offering. It
increases revenue per client and delivers higher value test
services on ingredients used in an expansive range of products -
from anti-viral, to shampoos to babies' nappies. The new service
replicates skin conditions of the scalp, face, mouth and abdomen.
It also utilises AI which has significantly improved the speed and
accuracy of testing ingredients on virtual skin models.
Gerard Brandon, CEO of DeepVerge, Commented:
"When we designed this new service we built on three key
platforms : Labskin's ability to grow human skin, its expertise in
replicating the skin's microbial environment from different parts
of the body and its increasing use of AI and data which helps with
speed, accuracy and insights. While we will fully launch the
product at conferences across all regions in 2021, it has already
resulted in significant interest and orders from existing and new
clients as well as from new clients in new sectors/markets.
The Labskin division has become a recognised global leader in
cloning and testing real-world human skin microbiome in a
laboratory with a rapidly expanding order book from a growing blue
chip client base. Since September 2019, the team has increased
revenue per client exponentially by offering multiple value-added
solutions beyond its core laboratory testing services which lower
client development costs of product information validation enabling
new products get to market faster."
For further information please contact:
+44 (0) 7340 055
DeepVerge plc Gerard Brandon, CEO 648
SPARK Advisory Partners Limited Neil Baldwin/Andrew +44 (0) 113 370
(Nominated Adviser) Emmott 8974
Turner Pope Investments (TPI) +44 (0) 20 3657
Limited (Broker) Andy Thacker/Zoe Alexander 0050
About DeepVerge plc (www.deepverge.com)
DeepVerge is a scientific research and AI-as-a-Service company
focused on production and analysis of bacteria, virus and toxins
utilising artificial intelligent data analytics in regulatory
technology, from scientifically proving the impact of skincare
product claims on skin microbiome for top 20 global cosmetic
company clients to remotely detecting water contamination in
real-time.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCURVNRRRUUAAA
(END) Dow Jones Newswires
December 11, 2020 02:00 ET (07:00 GMT)
Grafico Azioni Integumen (LSE:SKIN)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Integumen (LSE:SKIN)
Storico
Da Apr 2023 a Apr 2024